This Quality Improvement (QI) program aims to optimise pharmacological and non-pharmacological management of lipid abnormalities in patients with atherogenic dyslipidaemia, to achieve a reduction in cardiovascular disease risk in patients.
Staying abreast of all of the latest medical guidelines can be a tough gig for many busy primary care professionals. Dr Simon Cowap speaks on guiding his way through all of the guides available, and extracts his most important findings from the latest heart failure guidelines release.
Join CNC Ms Mary Roberts as she examines COPD in Australia, and provides some quality advice on what you can do to control breathlessness and ensure the best possible quality of life for your patients, in alignment with World COPD Day 2018.
This Quality Improvement (QI) Program aims to improve the management of patients with chronic heart failure with a LVEF (left ventricular ejection fraction) lower than 40%.
